FORT WORTH, Texas, April 20, 2015 /PRNewswire/ --
Orthobiologics are substances that are utilized by orthopedic surgeons for healing bone injuries. The orthobiologics market is a rewarding market, which represents a number of growth opportunities for its stakeholders. The global orthobiologics market report defines and segments the concerned market with analysis and forecast of revenue. The global orthobiologics market was valued at $5,712.4 million in 2014, and is projected to reach $7,900.2 million by 2019, at a CAGR of 6.7% from 2014 to 2019.
Browse through the TOC of global orthobiologics market for an in-depth analysis of the industry trends and segments, with help of various tables and figures.
Early buyers will receive 10% customization on this report.
The changing preference from mechanical to biological implants, accompanied by the rising awareness of orthobiologics is expediting the growth of this market. The orthobiologics market has seen an impressive growth since 2012, owing to increased research and development activities and rising demand for orthobiologics products.
North America contributes the largest market share in the global orthobiologics market, and is slated to grow further due to recent advancements made in the field of orthopedics. On the other hand, Asia is the fastest growing region in the global orthobiologics market by virtue of its exponential aging population as well as rising prevalence of diabetes and obesity.
Inquiry Before Buying @http://www.micromarketmonitor.com/contact/3559061506-inquery_before_buy.html
The global orthobiologics market is segmented on the basis of product, end-user, and geography. According to geographical segmentation, this market is classified into North America, Europe, Asia, and the rest of the world (RoW).
This report provides a comprehensive overview of market share and value chain analysis, in addition to in-depth insights on varied market metrics such as drivers, restraints and upcoming opportunities. The report also presents a competitive landscape and company profiles of key players in the market. Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.), Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.) are some of the leading players in the global orthobiologics market.
The North America Orthobiologics Market was valued at $1,724.5 million in 2014, and is expected to reach $2,493.5 million by 2019 at a CAGR of 7.7% from 2014 to 2019. The North American orthobiologics market has been segmented on the basis of product, end-user, and country. Orthobiologics market comprises products such as bone graft substitutes, stem cell therapy, bone allografts, viscosupplementation, and bone growth factor & spinal stimulation. The market has been further segmented on the basis of end-users into hospitals, Point of Care (POC) testing, and other end users. The North America Orthobiologics market consists of countries such as the U.S., Canada, and Mexico.
MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112
SOURCE MicroMarket Monitor